Evidence map›Paper›PMID 35756742›Full record

ReviewClinical kidney journal2022

Kidney-placenta crosstalk in health and disease.

Omar Cabarcas-Barbosa, Olivia Capalbo, Alberta Ferrero-Fernández, Carlos G Musso

Open access · goldAbstract readReview
In one paragraph

Review in Clinical kidney journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. The pathophysiology of pre-eclampsia.Nature reviews. Nephrology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Organ crosstalk and dysfunction in sepsis.Annals of intensive care · 2024
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Omar Cabarcas-BarbosaNephrology Department, Universidad Simon Bolivar, Barranquilla, Colombia.
Olivia CapalboPhysiology Department, Instituto Universitario del Hospital Italiano de Buenos Aires, Argentina.
Alberta Ferrero-FernándezPhysiology Department, Instituto Universitario del Hospital Italiano de Buenos Aires, Argentina.
Carlos G MussoPhysiology Department, Instituto Universitario del Hospital Italiano de Buenos Aires, Argentina.
Hospital Italiano de Buenos Aires · ARInstituto Universitario Hospital Italiano · ARUniversidad Simón Bolívar · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organ crosstalk allows the interaction between systems to adapt to a constant changing environment, maintaining homeostasis. The process of placentation and the new hormonal environment during pregnancy trigger physiological changes that modulate kidney function to control extracellular volume, acid-base balance and filtration of metabolic waste products. The bidirectional communication means that acute or chronic dysfunction of one organ can compromise the other. Abnormal placentation in pregnancy-related hypertensive disorders such as pre-eclampsia and HELLP (haemolysis, elevated liver enzymes and low platelet count) syndrome leads to the release of antiangiogenic factors that may cause kidney injury (thrombotic microangiopathy, glomeruloendotheliosis, mesangiolysis and vasoconstriction of peritubular vessels). These hypertensive disorders are a key cause of kidney injury in gestation, which increases maternal morbimortality and adverse foetal outcomes. Conversely, prior kidney injury or causes of kidney injury (diabetes, lupus, glomerulonephritis or other forms of chronic kidney disease) increase the risk of developing hypertensive pregnancy disorders, providing a baseline higher risk. Inherited kidney diseases are a special concern, given the potential for genetic predisposition to kidney disease in the foetus. Understanding the bidirectional potential for compromise from placenta to kidney and vice versa provides a better framework to limit damage to both organs and improve maternal and foetal outcomes.

Indexed as

crosstalkeclampsiaHELLP syndromekidneyplacenta

Identifiers

PMID35756742
PMCPMC9217636
OpenAlexW4226128674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.